177660-72-9 Usage
Imidazole ring
The core structure of the compound, a five-membered aromatic ring with one nitrogen atom and two hydrogen atoms.
Phenyl substituent
A benzene ring attached to the imidazole ring, which contributes to the compound's aromaticity and stability.
Methylsulfonyl substituent
A functional group consisting of a sulfur atom bonded to a methane group, attached to the phenyl ring. This group imparts a strong and distinctive odor to the compound.
Trifluoromethyl substituent
A functional group consisting of a carbon atom bonded to three fluorine atoms, attached to the imidazole ring. This group is electron-withdrawing and can affect the reactivity and polarity of the compound.
Antimicrobial properties
The ability to inhibit the growth of microorganisms, such as bacteria and fungi, making it a potential candidate for treating infections.
Antiviral properties
The ability to inhibit the replication of viruses, making it a potential candidate for treating viral infections.
Medicinal chemistry research
The study of the compound's unique structure and potential therapeutic applications, with the aim of developing new drugs.
Pharmaceutical development
The process of developing new drugs for the treatment of various diseases and conditions, in which the compound is of particular interest due to its diverse biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 177660-72-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,7,6,6 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 177660-72:
(8*1)+(7*7)+(6*7)+(5*6)+(4*6)+(3*0)+(2*7)+(1*2)=169
169 % 10 = 9
So 177660-72-9 is a valid CAS Registry Number.
177660-72-9Relevant articles and documents
METHOD OF USING CYCLOOXYGENASE-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF NEOPLASIA
-
, (2008/06/13)
This invention relates to the use of cyclooxygenase-2 inhibitors or derivatives thereof in preventing and treating neoplasia. In particular, the invention describes the method of preventing and treating epithelial cell neoplasia in a subject, said method comprising treating the subject with a therapeutically-effective amount of a compound of Formula (I) wherein A, R and R are as described in the specification.
Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammation
-
, (2008/06/13)
The present invention provides the use of a COX-2 inhibitior and an NK-1 receptor antagonist for the treatment or prevention of inflammatory disorders.
Combination therapy in the prevention of cardiovascular disorders
-
, (2008/06/13)
This invention relates to the use of cyclooxygenase-2 inhibitors or derivatives thereof in preventing cardiovascular disorders.
